Lite Strategy, Inc. (LITS)
0.9804
-0.02
(-1.96%)
USD |
NASDAQ |
Aug 28, 16:00
1.01
+0.03
(+3.02%)
After-Hours: 20:00
Lite Strategy Cash from Operations (Quarterly) : -1.52M for March 31, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.52M |
| December 31, 2025 | -1.929M |
| September 30, 2025 | -4.508M |
| June 30, 2025 | -2.461M |
| March 31, 2025 | -3.267M |
| December 31, 2024 | -3.666M |
| September 30, 2024 | -11.45M |
| June 30, 2024 | -18.21M |
| March 31, 2024 | -2.928M |
| December 31, 2023 | -11.06M |
| September 30, 2023 | -18.49M |
| June 30, 2023 | -11.30M |
| March 31, 2023 | -12.13M |
| December 31, 2022 | -14.27M |
| September 30, 2022 | -14.78M |
| June 30, 2022 | -15.50M |
| March 31, 2022 | -16.96M |
| December 31, 2021 | -8.566M |
| September 30, 2021 | -7.721M |
| June 30, 2021 | -11.26M |
| March 31, 2021 | -15.65M |
| December 31, 2020 | 4.05M |
| September 30, 2020 | -9.111M |
| June 30, 2020 | 69.11M |
| March 31, 2020 | -10.30M |
| Date | Value |
|---|---|
| December 31, 2019 | -10.48M |
| September 30, 2019 | -14.08M |
| June 30, 2019 | -8.064M |
| March 31, 2019 | -11.34M |
| December 31, 2018 | 2.799M |
| September 30, 2018 | -12.82M |
| June 30, 2018 | -3.75M |
| March 31, 2018 | -6.239M |
| December 31, 2017 | -4.751M |
| September 30, 2017 | -6.562M |
| June 30, 2017 | -3.146M |
| March 31, 2017 | 1.606M |
| December 31, 2016 | -3.747M |
| September 30, 2016 | 8.773M |
| June 30, 2016 | -3.483M |
| March 31, 2016 | -4.385M |
| December 31, 2015 | -4.228M |
| September 30, 2015 | -5.761M |
| June 30, 2015 | -6.742M |
| March 31, 2015 | -8.148M |
| December 31, 2014 | -6.448M |
| September 30, 2014 | -6.731M |
| June 30, 2014 | -5.85M |
| March 31, 2014 | -5.071M |
| December 31, 2013 | -4.467M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -7.588M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Anika Therapeutics, Inc. | -0.684M |
| Savara, Inc. | -29.75M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.098M |
| Cash from Financing (Quarterly) | -1.792M |
| Free Cash Flow | -110.42M |
| Free Cash Flow Per Share (Quarterly) | -2.843 |
| Free Cash Flow to Equity (Quarterly) | -101.52M |
| Free Cash Flow to Firm (Quarterly) | -101.52M |
| Free Cash Flow Yield | -412.5% |